BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 1, 2005
View Archived Issues
GSK-3 inhibition highlighted as important new avenue for mood disorder therapies / News in Context
Read More
Electrophysiological characterization of two 5-HT1A receptor inverse agonists
Read More
TB-1-099: A novel allosteric modulator of SERT
Read More
Chymase inhibition represents a novel strategy for treatment of scleroderma
Read More
Experimental evidence for 5-HT7's role in emotion
Read More
Genentech licenses TAP technology for use with therapeutic antibodies
Read More
DOR and Dowpharma sign joint development agreement for BT-VACC
Read More
Phase I study of Progenics' novel HIV entry inhibitor completes enrollment
Read More
GCAN-101 begins phase II study for metastatic cancers
Read More
NDA accepted for filing for InKine's next-generation purgative product
Read More
Milestone in Arena and Merck & Co. cardiovascular collaboration
Read More
Valeant to develop Viramidine in Japan
Read More
Teva to acquire Ivax
Read More
HCV-I.E.T. studied in phase I/II trial for hepatitis C
Read More
HIV-1 protease inhibitor lopinavir demonstrates antimalarial activity in vitro
Read More
Tirapazamine attenuates tumor metastasis in vivo
Read More
Nippon Boehringer Ingelheim to solely market Alesion
Read More
New therapeutics for cancer disclosed in recent patents
Read More
Novel TACE inhibitors claimed in recent patent literature
Read More
Paratek studies new broad-spectrum antibiotic PTK-0796 in phase I trial
Read More
Noxafil recommended for approval in Europe
Read More
Expanded indication for Remicade recommended for approval in Europe
Read More
Kepivance receives positive opinion in Europe for oral mucositis
Read More
Positive opinion handed down for Xolair in Europe
Read More
Recent patents describe novel antiinfective agents
Read More
New release of Prous Science Integrity(R) with technology and content enhancements
Read More